NewsStackNewsStack
Daily Brief: Which companies are hyping vs delivering: red flags, real signals and repeat offenders, free daily.

OBIO

NYSE:MDTNYSE
18 announcements
Credibility Score74%
Medtronic to acquire Contego Medical, expanding access to next-generation carotid therapies
OverhypedModerate hypeunclear

Medtronic is acquiring Contego Medical for $380 million to expand its vascular portfolio.

about 1 hour ago
▼
Medtronic announces positive results from real-world registries for the Sphere-9™ catheter and PulseSelect™ PFA System at APHRS 2026
OverhypedModerate hypeunclear

Medtronic reports strong real-world safety and efficacy data for its cardiac ablation systems.

22 Oct 2026, 11:00 UTC
▼
Medtronic Named to TIME Best Inventions of 2026 List for Stealth AXiS™ surgical system and Corsano™* multi-parameter wearable
Routineunclear

Medtronic wins TIME Best Inventions honors for two connected health technologies.

15 Oct 2026, 20:30 UTC
▼
Medtronic Announces Final Results of MiniMed Group, Inc. Exchange Offer
Routineunclear

Medtronic fully divests MiniMed via oversubscribed share exchange, finalizing separation immediately.

14 Oct 2026, 12:00 UTC
▼
Medtronic Announces Preliminary Results of MiniMed Group, Inc. Exchange Offer
Routineunclear

Medtronic's oversubscribed MiniMed share exchange will fully divest its MiniMed stake.

12 Oct 2026, 12:45 UTC
▼
Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.
Routineunclear

Medtronic finalizes MiniMed exchange ratio; offer closes October 9, 2026.

7 Oct 2026, 21:31 UTC
▼
Cornerstone Robotics Announces Strategic Partnership with Medtronic to Expand Global Access to Robotic-assisted Surgery
Routineunclear

Medtronic and Cornerstone Robotics announce a partnership with no disclosed financial terms.

1 Sep 2026, 12:23 UTC
▼
Medtronic reports first quarter fiscal 2027 results; delivers broad-based portfolio performance and raises fiscal 2027 guidance
OverhypedModerate hypeunclear

Medtronic touts growth but provides no financial figures to back its claims.

1 Sep 2026, 10:53 UTC
▼
Medtronic Announces Strategic Investment in Pi-Cardia to Accelerate Innovation for Complex TAVR
Routineunclear

Medtronic invests in Pi-Cardia but discloses no terms or financial details.

1 Sep 2026, 10:32 UTC
▼
Medtronic announces cash dividend for second quarter of fiscal year 2027
RoutineModerate hypeunclear

Medtronic confirms a $0.72 quarterly dividend, extending its 49-year increase streak.

20 Aug 2026, 20:53 UTC
▼
Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain
OverhypedModerate hypeunclear

Medtronic’s $650M deal is real, but the financial upside is distant and unproven.

16 Jul 2026, 13:11 UTC
▼
Medtronic completes acquisition of Scientia Vascular, seamlessly integrating access and therapeutic portfolios for neurovascular care
OverhypedModerate hypeunclear

Medtronic’s $550M deal is bold but long on hype, short on hard numbers.

12 Jun 2026, 15:12 UTC
▼
Medtronic announces strategic investments to support future expansion of cardiac ablation portfolio as physician demand for Affera™ technologies broadens
OverhypedModerate hypeunclear

Medtronic’s ICE investments are bold but lack financial detail and near-term payoff clarity.

3 Jun 2026, 10:58 UTC
▼
Medtronic reports fourth quarter and full year fiscal 2026 results; delivers highest annual revenue growth in 10 years
Genuine Signalimproving

Medtronic delivers solid growth, but some claims lack full supporting detail for investors.

3 Jun 2026, 10:55 UTC
▼
Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain
OverhypedModerate hypeunclear

Big promise, big price tag, but little hard data—wait for real numbers before acting.

20 May 2026, 13:25 UTC
▼
Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
OverhypedModerate hypeimproving

Funding is real, but clinical and commercial payoffs are still years away and unproven.

6 May 2026, 12:26 UTC
▼
Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
Routineunclear

This is a routine event update with no financial or strategic substance for investors.

23 Apr 2026, 16:13 UTC
▼